Nike + Transitions = Nike MAX Transitions sunglasses

Article

Pinellas Park, FL—Nike Vision and Transitions Optical introduced new Nike MAX Transitions adaptive sunglasses at the Transitions Championship PGA TOUR event. Available in two colors, the lenses are responsive to changing light and specifically engineered for sport performance including golf, hiking and trail running.

Pinellas Park, FL-Nike Vision and Transitions Optical introduced new Nike MAX Transitions adaptive sunglasses at the Transitions Championship PGA TOUR event.  Available in two colors, the lenses are responsive to changing light and specifically engineered for sport performance including golf, hiking and trail running.

Nike MAX Transitions sunglasses feature two tints, engineered precisely to enhance the visual details of the natural environment encountered during specific sports and activities.

Nike MAX Transitions/Golf Tint – a violet color designed to improve contour recognition on the greens and increase ball pop.

Nike MAX Transitions/Outdoor Tint – a green color that brightens the shadows, increases contrast and enhances the visual spectrum in natural environments – like hiking and trails, as well as fairways and greens.

The sunglasses are available in several popular Nike styles, including Show X2 style, designed to deliver grip, stability and comfort, with adjustable temples and an adjustable ventilated nose for stability, and reduced fogging; and SQ frames, which provide wide coverage with minimal visual interference and are ideal for golf and training.

For more information: Transitionssunwear.com or Transitions.com.

For more articles in this issue of InDispensable, click here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
© 2025 MJH Life Sciences

All rights reserved.